A New Class of Therapy: Monoclonal Antibody Fragments
Monoclonal Antibodies: Monoclonal antibodies (mAbs) are clones of the antibodies that our body secretes...
read Details
C> is vulnerable to violent shock during transportation.
C> is vulnerable to violent shock during transportation.
Modality Solutions is paving the way for the future of pharmaceutical transportation testing.
The global cold chain requires non-standard modes of transportation like speedboats, helicopters, drones, and more. Lack of infrastructure shouldn’t stop therapies from getting where they need to go. Real-world shipping tests aren’t effective for measuring viability, which is why Modality Solutions’ Advantage Transport Simulation Laboratory™ conducts worst-case scenarios.
Stay on top of the industry trends
You may also like
Non-Standard Modes of Transportation for Cell & Gene Therapies | Executive Insights with Carson Dickey
Recently, while attending the Allogenic Cell Therapy Summit in Boston, MA, Carson was at...
read Details
Executive Insights with Rob Battista
We sat down with Rob Battista, Engineering Manager, to dive into his insights on...
read Details